Page 59 - 2020Taiwan Food and Drug Administration Annual Report

Management of Controlled Drugs
04c
and Prevention of Drug Abuse

TFDA has established a drug abuse monitoring mechanism, to effectively manage the
controlled drugs and prevent drug abuse, as well as to understand the domestic trend and
investigate the international information on the emerging substances of drug abuse, to be used
as a reference for the illegal drugs management of Ministry of Justice. In addition, Ministry of
-XVWLFH SODFHV WKH HPHUJLQJ GUXJV ZLWK VFLHQWL¿F XVH LQWR WKH ³Controlled Drugs Act,” to avoid
drug leakage and endanger the health of the citizens in the nation. TFDA has also actively

cooperated with the Executive Yuan to implement multiple anti-drug measures and strengthen
the anti-drug dissemination.

4FDUJPO c1SPNPUF "NFOENFOU UP UIF 3FHVMBUJPOT PO

$POUSPMMFE %SVHT

Introduction of the Polic y
Introduction of the Policy
Taiwan regularly reviews and makes amendments to the regulations related to the

“Controlled Drugs Act” to prevent the abuse or illegal use of controlled drugs; and go through
the international interactions to link and follow international trends of the issue.

Implementation Strategy
Implementation Strate gy
The meeting was held by “Controlled Drugs Review Committee of the Ministry of Health
and Welfare” in every six months to conduct the assessment and management for the new
narcotics that have necessary to use under scientific consideration. In addition, the seminar
of “2019 International Conference on Narcotics: Safe Use and Management” was held on

September 4, 2019 to share and exchange the current status of the management of controlled
drugs in various countries and measures to prevent and iatrogenic treatment addiction.
In addition, the “Regulations Governing Management of Manufacturing Schedule 1 and 2
Controlled Drugs Commissioned to Pharmaceutical Firms” was announced on May 23, 2019 in
accordance with Article 4 of the Controlled Drugs Act amended and announced on June 4, 2017.

57